What YCharOS Inc. does

YCharOS Inc. is a privately held, for-profit biotechnology company founded in 2019 that characterizes commercially available reagent antibodies and disseminates open science data covering all human proteins. The company operates with a small team in the 1-10 employee range and maintains a public-facing website at ycharos.com, though detailed operational, product, and technology information could not be retrieved from the source at the time of analysis — the website returned only a JavaScript-based verification/loading page.

The company's stated mission centers on antibody reagent characterization, a quality-control function of growing importance in life sciences research amid widespread reproducibility concerns, combined with an open-science dissemination model. This positioning suggests a reference-data or platform business aimed at academic researchers, biotech developers, and reagent manufacturers seeking independent antibody validation. By publishing characterization data openly rather than restricting access, the company aligns itself with the open-science movement within the antibody reagent market.

There is no documented information in the source material about YCharOS's pricing model, go-to-market strategy, customer segments, geographic footprint, revenue, funding history, leadership team, products, partnerships, or strategic initiatives. The only available metadata is the firm's foundational profile — founding year, small headcount range, for-profit status, and mission statement. Consequently, any assessment of business model mechanics, revenue traction, competitive positioning, or strategic direction is necessarily limited by the data gap.

Name

YCharOS Inc.

Website

https://ycharos.com

Company type

Private

Founded year

2019

Headcount range

1–10 employees

Short description

YCharOS Inc. is a privately held, for-profit biotechnology company founded in 2019 that characterizes commercially available reagent antibodies and shares open science data covering all human proteins for the research community.

Ownership category

akta.pro rank

Product category

Antibody Characterization Services

NAICS

Testing Laboratories and Services (541380), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Antibody characterization services
• Reagent antibody validation
• Open science data
• Protein research reagents
• Antibody reproducibility testing

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

YCharOS Inc. characterizes commercially available reagent antibodies and shares open science data covering all human proteins. The company provides independent antibody validation work intended to support reproducible life sciences research.

Differentiator

Problem solved

Functional benefit

Products and services

• Antibody Characterization Service
• Open Science Antibody Characterization Data

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Abcam: A leading global antibody reagent supplier (now part of Danaher) that has invested heavily in knockout-validation programs for its catalog — directly overlapping with YCharOS's antibody characterization mission at much larger scale.
• Cell Signaling Technology: Major antibody manufacturer with a large validation-focused catalog and ongoing initiatives to characterize antibody specificity using genetic and orthogonal methods — a broader incumbent pursuing similar quality goals.
• Proteintech: Independent antibody manufacturer with a large catalog and an emphasis on validation using knockout/knock-in cell lines, making it a directly comparable reagent-quality focused competitor.
• Thermo Fisher Scientific: Diversified life sciences tools giant whose Invitrogen and other antibody brands compete in reagent validation; relevant as a broad incumbent whose scale and internal validation programs can overshadow niche efforts.
• Bio-Techne: Manufacturer of research reagents including antibodies under the R&D Systems brand; an incumbent with internal validation efforts and proteomics-adjacent product lines comparable to YCharOS's domain.
• GeneTex: Antibody reagent vendor with ongoing initiatives to validate antibodies via genetic strategies, positioning it as another incumbent in the same antibody-quality / characterization space.

Emerging players

• BenchSci: AI-powered antibody search and data platform that aggregates published validation figures and figures from commercial suppliers — an emerging data-and-software peer that helps researchers navigate the same antibody-quality problem YCharOS addresses.
• Addgene: Non-profit plasmid repository that supports reproducible life science research through open sharing of validated reagents — comparable as an open-science, quality-focused enabler in the research-reagents ecosystem.

Direct peers

• Atlas Antibodies: Develops and validates antibodies targeting the human proteome via the Human Protein Atlas project — closely aligned with YCharOS's proteome-wide antibody characterization mission and open-science orientation.

Others

• Antibody Registry: Public registry assigning unique identifiers to antibodies to reduce ambiguity in publications — an open-data ecosystem peer that complements YCharOS's mission of improving antibody reproducibility.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YCharOS Inc.